Report Detail

Pharma & Healthcare Global Oseltamivir Phosphate Capsules Market Research Report 2022

  • RnM4438755
  • |
  • 11 May, 2022
  • |
  • Global
  • |
  • 108 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 Oseltamivir Phosphate Capsules Market Overview

    • 1.1 Product Overview and Scope of Oseltamivir Phosphate Capsules
    • 1.2 Oseltamivir Phosphate Capsules Segment by Type
      • 1.2.1 Global Oseltamivir Phosphate Capsules Sales Growth Rate Comparison by Type (2022-2028)
      • 1.2.2 30mg
      • 1.2.3 45mg
      • 1.2.4 75mg
    • 1.3 Oseltamivir Phosphate Capsules Segment by Application
      • 1.3.1 Global Oseltamivir Phosphate Capsules Sales Comparison by Application: (2022-2028)
      • 1.3.2 Influenza Treatment
      • 1.3.3 Influenza Prevention
    • 1.4 Global Oseltamivir Phosphate Capsules Market Size Estimates and Forecasts
      • 1.4.1 Global Oseltamivir Phosphate Capsules Revenue 2017-2028
      • 1.4.2 Global Oseltamivir Phosphate Capsules Sales 2017-2028
      • 1.4.3 Oseltamivir Phosphate Capsules Market Size by Region: 2017 Versus 2021 Versus 2028

    2 Oseltamivir Phosphate Capsules Market Competition by Manufacturers

    • 2.1 Global Oseltamivir Phosphate Capsules Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Oseltamivir Phosphate Capsules Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Oseltamivir Phosphate Capsules Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Oseltamivir Phosphate Capsules Manufacturing Sites, Area Served, Product Type
    • 2.5 Oseltamivir Phosphate Capsules Market Competitive Situation and Trends
      • 2.5.1 Oseltamivir Phosphate Capsules Market Concentration Rate
      • 2.5.2 The Global Top 5 and Top 10 Largest Oseltamivir Phosphate Capsules Players Market Share by Revenue
      • 2.5.3 Global Oseltamivir Phosphate Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

    3 Oseltamivir Phosphate Capsules Retrospective Market Scenario by Region

    • 3.1 Global Oseltamivir Phosphate Capsules Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Oseltamivir Phosphate Capsules Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Oseltamivir Phosphate Capsules Market Facts & Figures by Country
      • 3.3.1 North America Oseltamivir Phosphate Capsules Sales by Country
      • 3.3.2 North America Oseltamivir Phosphate Capsules Revenue by Country
      • 3.3.3 United States
      • 3.3.4 Canada
    • 3.4 Europe Oseltamivir Phosphate Capsules Market Facts & Figures by Country
      • 3.4.1 Europe Oseltamivir Phosphate Capsules Sales by Country
      • 3.4.2 Europe Oseltamivir Phosphate Capsules Revenue by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Oseltamivir Phosphate Capsules Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Oseltamivir Phosphate Capsules Sales by Region
      • 3.5.2 Asia Pacific Oseltamivir Phosphate Capsules Revenue by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 China Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
    • 3.6 Latin America Oseltamivir Phosphate Capsules Market Facts & Figures by Country
      • 3.6.1 Latin America Oseltamivir Phosphate Capsules Sales by Country
      • 3.6.2 Latin America Oseltamivir Phosphate Capsules Revenue by Country
      • 3.6.3 Mexico
      • 3.6.4 Brazil
      • 3.6.5 Argentina
    • 3.7 Middle East and Africa Oseltamivir Phosphate Capsules Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Oseltamivir Phosphate Capsules Sales by Country
      • 3.7.2 Middle East and Africa Oseltamivir Phosphate Capsules Revenue by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 UAE

    4 Global Oseltamivir Phosphate Capsules Historic Market Analysis by Type

    • 4.1 Global Oseltamivir Phosphate Capsules Sales Market Share by Type (2017-2022)
    • 4.2 Global Oseltamivir Phosphate Capsules Revenue Market Share by Type (2017-2022)
    • 4.3 Global Oseltamivir Phosphate Capsules Price by Type (2017-2022)

    5 Global Oseltamivir Phosphate Capsules Historic Market Analysis by Application

    • 5.1 Global Oseltamivir Phosphate Capsules Sales Market Share by Application (2017-2022)
    • 5.2 Global Oseltamivir Phosphate Capsules Revenue Market Share by Application (2017-2022)
    • 5.3 Global Oseltamivir Phosphate Capsules Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 Natco Pharma
      • 6.1.1 Natco Pharma Corporation Information
      • 6.1.2 Natco Pharma Description and Business Overview
      • 6.1.3 Natco Pharma Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 6.1.4 Natco Pharma Oseltamivir Phosphate Capsules Product Portfolio
      • 6.1.5 Natco Pharma Recent Developments/Updates
    • 6.2 Roche Pharma
      • 6.2.1 Roche Pharma Corporation Information
      • 6.2.2 Roche Pharma Description and Business Overview
      • 6.2.3 Roche Pharma Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 6.2.4 Roche Pharma Oseltamivir Phosphate Capsules Product Portfolio
      • 6.2.5 Roche Pharma Recent Developments/Updates
    • 6.3 HEC
      • 6.3.1 HEC Corporation Information
      • 6.3.2 HEC Description and Business Overview
      • 6.3.3 HEC Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 6.3.4 HEC Oseltamivir Phosphate Capsules Product Portfolio
      • 6.3.5 HEC Recent Developments/Updates
    • 6.4 Zentiva
      • 6.4.1 Zentiva Corporation Information
      • 6.4.2 Zentiva Description and Business Overview
      • 6.4.3 Zentiva Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 Zentiva Oseltamivir Phosphate Capsules Product Portfolio
      • 6.4.5 Zentiva Recent Developments/Updates
    • 6.5 Taj Pharma
      • 6.5.1 Taj Pharma Corporation Information
      • 6.5.2 Taj Pharma Description and Business Overview
      • 6.5.3 Taj Pharma Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 6.5.4 Taj Pharma Oseltamivir Phosphate Capsules Product Portfolio
      • 6.5.5 Taj Pharma Recent Developments/Updates
    • 6.6 Sawai Pharmaceutical
      • 6.6.1 Sawai Pharmaceutical Corporation Information
      • 6.6.2 Sawai Pharmaceutical Description and Business Overview
      • 6.6.3 Sawai Pharmaceutical Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 6.6.4 Sawai Pharmaceutical Oseltamivir Phosphate Capsules Product Portfolio
      • 6.6.5 Sawai Pharmaceutical Recent Developments/Updates
    • 6.7 MSN Laboratories
      • 6.6.1 MSN Laboratories Corporation Information
      • 6.6.2 MSN Laboratories Description and Business Overview
      • 6.6.3 MSN Laboratories Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 MSN Laboratories Oseltamivir Phosphate Capsules Product Portfolio
      • 6.7.5 MSN Laboratories Recent Developments/Updates
    • 6.8 Hetero Healthcare
      • 6.8.1 Hetero Healthcare Corporation Information
      • 6.8.2 Hetero Healthcare Description and Business Overview
      • 6.8.3 Hetero Healthcare Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 6.8.4 Hetero Healthcare Oseltamivir Phosphate Capsules Product Portfolio
      • 6.8.5 Hetero Healthcare Recent Developments/Updates
    • 6.9 Cipla
      • 6.9.1 Cipla Corporation Information
      • 6.9.2 Cipla Description and Business Overview
      • 6.9.3 Cipla Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 6.9.4 Cipla Oseltamivir Phosphate Capsules Product Portfolio
      • 6.9.5 Cipla Recent Developments/Updates
    • 6.10 Amneal Pharmaceuticals
      • 6.10.1 Amneal Pharmaceuticals Corporation Information
      • 6.10.2 Amneal Pharmaceuticals Description and Business Overview
      • 6.10.3 Amneal Pharmaceuticals Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 6.10.4 Amneal Pharmaceuticals Oseltamivir Phosphate Capsules Product Portfolio
      • 6.10.5 Amneal Pharmaceuticals Recent Developments/Updates
    • 6.11 Brilliant Pharmaceutical
      • 6.11.1 Brilliant Pharmaceutical Corporation Information
      • 6.11.2 Brilliant Pharmaceutical Oseltamivir Phosphate Capsules Description and Business Overview
      • 6.11.3 Brilliant Pharmaceutical Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 6.11.4 Brilliant Pharmaceutical Oseltamivir Phosphate Capsules Product Portfolio
      • 6.11.5 Brilliant Pharmaceutical Recent Developments/Updates
    • 6.12 BrightGene
      • 6.12.1 BrightGene Corporation Information
      • 6.12.2 BrightGene Oseltamivir Phosphate Capsules Description and Business Overview
      • 6.12.3 BrightGene Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 6.12.4 BrightGene Oseltamivir Phosphate Capsules Product Portfolio
      • 6.12.5 BrightGene Recent Developments/Updates
    • 6.13 Kelun Pharmaceutical
      • 6.13.1 Kelun Pharmaceutical Corporation Information
      • 6.13.2 Kelun Pharmaceutical Oseltamivir Phosphate Capsules Description and Business Overview
      • 6.13.3 Kelun Pharmaceutical Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 6.13.4 Kelun Pharmaceutical Oseltamivir Phosphate Capsules Product Portfolio
      • 6.13.5 Kelun Pharmaceutical Recent Developments/Updates
    • 6.14 Qilu Pharmaceutical
      • 6.14.1 Qilu Pharmaceutical Corporation Information
      • 6.14.2 Qilu Pharmaceutical Oseltamivir Phosphate Capsules Description and Business Overview
      • 6.14.3 Qilu Pharmaceutical Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 6.14.4 Qilu Pharmaceutical Oseltamivir Phosphate Capsules Product Portfolio
      • 6.14.5 Qilu Pharmaceutical Recent Developments/Updates
    • 6.15 CSPC
      • 6.15.1 CSPC Corporation Information
      • 6.15.2 CSPC Oseltamivir Phosphate Capsules Description and Business Overview
      • 6.15.3 CSPC Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 6.15.4 CSPC Oseltamivir Phosphate Capsules Product Portfolio
      • 6.15.5 CSPC Recent Developments/Updates
    • 6.16 Zhijun Pingshan
      • 6.16.1 Zhijun Pingshan Corporation Information
      • 6.16.2 Zhijun Pingshan Oseltamivir Phosphate Capsules Description and Business Overview
      • 6.16.3 Zhijun Pingshan Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 6.16.4 Zhijun Pingshan Oseltamivir Phosphate Capsules Product Portfolio
      • 6.16.5 Zhijun Pingshan Recent Developments/Updates
    • 6.17 Zhongxi Sunve
      • 6.17.1 Zhongxi Sunve Corporation Information
      • 6.17.2 Zhongxi Sunve Oseltamivir Phosphate Capsules Description and Business Overview
      • 6.17.3 Zhongxi Sunve Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 6.17.4 Zhongxi Sunve Oseltamivir Phosphate Capsules Product Portfolio
      • 6.17.5 Zhongxi Sunve Recent Developments/Updates

    7 Oseltamivir Phosphate Capsules Manufacturing Cost Analysis

    • 7.1 Oseltamivir Phosphate Capsules Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Oseltamivir Phosphate Capsules
    • 7.4 Oseltamivir Phosphate Capsules Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Oseltamivir Phosphate Capsules Distributors List
    • 8.3 Oseltamivir Phosphate Capsules Customers

    9 Oseltamivir Phosphate Capsules Market Dynamics

    • 9.1 Oseltamivir Phosphate Capsules Industry Trends
    • 9.2 Oseltamivir Phosphate Capsules Market Drivers
    • 9.3 Oseltamivir Phosphate Capsules Market Challenges
    • 9.4 Oseltamivir Phosphate Capsules Market Restraints

    10 Global Market Forecast

    • 10.1 Oseltamivir Phosphate Capsules Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Oseltamivir Phosphate Capsules by Type (2023-2028)
      • 10.1.2 Global Forecasted Revenue of Oseltamivir Phosphate Capsules by Type (2023-2028)
    • 10.2 Oseltamivir Phosphate Capsules Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Oseltamivir Phosphate Capsules by Application (2023-2028)
      • 10.2.2 Global Forecasted Revenue of Oseltamivir Phosphate Capsules by Application (2023-2028)
    • 10.3 Oseltamivir Phosphate Capsules Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Oseltamivir Phosphate Capsules by Region (2023-2028)
      • 10.3.2 Global Forecasted Revenue of Oseltamivir Phosphate Capsules by Region (2023-2028)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      Summary:

      Industry Insights
      Due to the COVID-19 pandemic, the global Oseltamivir Phosphate Capsules market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Oseltamivir Phosphate Capsules market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Oseltamivir Phosphate Capsules landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
      30mg accounting for % of the Oseltamivir Phosphate Capsules global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Influenza Treatment segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
      The global major manufacturers of Oseltamivir Phosphate Capsules include Natco Pharma, Roche Pharma, HEC, Zentiva, Taj Pharma, Sawai Pharmaceutical, MSN Laboratories, Hetero Healthcare and Cipla, etc. In terms of revenue, the global 3 largest players have a % market share of Oseltamivir Phosphate Capsules in 2021.
      This report focuses on Oseltamivir Phosphate Capsules volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Oseltamivir Phosphate Capsules market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
      Key Drivers & Barriers
      High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
      Post-covid-19 Outlook
      The readers in the section will understand how the Oseltamivir Phosphate Capsules market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
      Segmental Outlook
      Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
      Segment by Type
      30mg
      45mg
      75mg
      Segment by Application
      Influenza Treatment
      Influenza Prevention
      Regional Outlook
      This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Scenario
      In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
      Natco Pharma
      Roche Pharma
      HEC
      Zentiva
      Taj Pharma
      Sawai Pharmaceutical
      MSN Laboratories
      Hetero Healthcare
      Cipla
      Amneal Pharmaceuticals
      Brilliant Pharmaceutical
      BrightGene
      Kelun Pharmaceutical
      Qilu Pharmaceutical
      CSPC
      Zhijun Pingshan
      Zhongxi Sunve
      Frequently Asked Questions
      Which product segment grabbed the largest share in the Oseltamivir Phosphate Capsules market?
      How is the competitive scenario of the Oseltamivir Phosphate Capsules market?
      Which are the key factors aiding the Oseltamivir Phosphate Capsules market growth?
      Which are the prominent players in the Oseltamivir Phosphate Capsules market?
      Which region holds the maximum share in the Oseltamivir Phosphate Capsules market?
      What will be the CAGR of the Oseltamivir Phosphate Capsules market during the forecast period?
      Which application segment emerged as the leading segment in the Oseltamivir Phosphate Capsules market?
      What key trends are likely to emerge in the Oseltamivir Phosphate Capsules market in the coming years?
      What will be the Oseltamivir Phosphate Capsules market size by 2028?
      Which company held the largest share in the Oseltamivir Phosphate Capsules market?


      Summary:
      Get latest Market Research Reports on Oseltamivir Phosphate Capsules. Industry analysis & Market Report on Oseltamivir Phosphate Capsules is a syndicated market report, published as Global Oseltamivir Phosphate Capsules Market Research Report 2022. It is complete Research Study and Industry Analysis of Oseltamivir Phosphate Capsules market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,317.10
      4,634.20
      2,705.70
      5,411.40
      368,068.00
      736,136.00
      224,634.00
      449,268.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report